Cargando…

Cost of anxiety disorders in Japan in 2008: a prevalence-based approach

BACKGROUND: The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sado, Mitsuhiro, Takechi, Sayuri, Inagaki, Ataru, Fujisawa, Daisuke, Koreki, Akihiro, Mimura, Masaru, Yoshimura, Kimio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878364/
https://www.ncbi.nlm.nih.gov/pubmed/24350841
http://dx.doi.org/10.1186/1471-244X-13-338
_version_ 1782297791349915648
author Sado, Mitsuhiro
Takechi, Sayuri
Inagaki, Ataru
Fujisawa, Daisuke
Koreki, Akihiro
Mimura, Masaru
Yoshimura, Kimio
author_facet Sado, Mitsuhiro
Takechi, Sayuri
Inagaki, Ataru
Fujisawa, Daisuke
Koreki, Akihiro
Mimura, Masaru
Yoshimura, Kimio
author_sort Sado, Mitsuhiro
collection PubMed
description BACKGROUND: The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden. METHOD: A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics. RESULTS: The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US$1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion. CONCLUSIONS: The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation.
format Online
Article
Text
id pubmed-3878364
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38783642014-01-07 Cost of anxiety disorders in Japan in 2008: a prevalence-based approach Sado, Mitsuhiro Takechi, Sayuri Inagaki, Ataru Fujisawa, Daisuke Koreki, Akihiro Mimura, Masaru Yoshimura, Kimio BMC Psychiatry Research Article BACKGROUND: The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden. METHOD: A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics. RESULTS: The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US$1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion. CONCLUSIONS: The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation. BioMed Central 2013-12-18 /pmc/articles/PMC3878364/ /pubmed/24350841 http://dx.doi.org/10.1186/1471-244X-13-338 Text en Copyright © 2013 Sado et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sado, Mitsuhiro
Takechi, Sayuri
Inagaki, Ataru
Fujisawa, Daisuke
Koreki, Akihiro
Mimura, Masaru
Yoshimura, Kimio
Cost of anxiety disorders in Japan in 2008: a prevalence-based approach
title Cost of anxiety disorders in Japan in 2008: a prevalence-based approach
title_full Cost of anxiety disorders in Japan in 2008: a prevalence-based approach
title_fullStr Cost of anxiety disorders in Japan in 2008: a prevalence-based approach
title_full_unstemmed Cost of anxiety disorders in Japan in 2008: a prevalence-based approach
title_short Cost of anxiety disorders in Japan in 2008: a prevalence-based approach
title_sort cost of anxiety disorders in japan in 2008: a prevalence-based approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878364/
https://www.ncbi.nlm.nih.gov/pubmed/24350841
http://dx.doi.org/10.1186/1471-244X-13-338
work_keys_str_mv AT sadomitsuhiro costofanxietydisordersinjapanin2008aprevalencebasedapproach
AT takechisayuri costofanxietydisordersinjapanin2008aprevalencebasedapproach
AT inagakiataru costofanxietydisordersinjapanin2008aprevalencebasedapproach
AT fujisawadaisuke costofanxietydisordersinjapanin2008aprevalencebasedapproach
AT korekiakihiro costofanxietydisordersinjapanin2008aprevalencebasedapproach
AT mimuramasaru costofanxietydisordersinjapanin2008aprevalencebasedapproach
AT yoshimurakimio costofanxietydisordersinjapanin2008aprevalencebasedapproach